Lin Xicheninsider trades
In SEC Form 4 filings, Lin Xichen is listed as CHIEF SCIENTIFIC OFFICER of Structure Therapeutics Inc. (GPCR). Lin Xichen reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 2.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| GPCRStructure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | 7 | Sep 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | M | 17,817 | $0.34 | $6,058 | 246,777 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | C | 17,817 | $0.00 | $0 | 228,960 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | M · derivative | 17,817 | $0.34 | $6,058 | 125,081 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | C · derivative | 5,939 | $0.00 | $0 | 5,939 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | S · derivative | 1,300 | $45.86 | Sale −$59,623 | 4,639 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | S · derivative | 4,539 | $47.20 | Sale −$214,254 | 100 | Yes | Form 4 |
| GPCRStructure Therapeutics Inc. | Sep 1 | Sep 2 | S · derivative | 100 | $47.83 | Sale −$4,783 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.